Latest news with #Virtus'
Yahoo
17-07-2025
- Business
- Yahoo
100 jobs to be created as drone company Stark plans new factory
Swindon will soon be at the forefront of the high-tech defence industry when German company Stark starts manufacturing its cutting-edge military drones here. The move will create around 100 jobs for the town. The Swindon factory will be the first facility Stark has outside of Germany and will build the company's AI-assisted unmanned drones. Mike Armstrong, managing director of Stark UK, said: 'The UK and Germany are world leaders in new technology that will define the battlefields of the future. We need rapid and scalable production to protect our people, defend our sovereignty and deter aggression. That means resilient supply chains which stretch across Europe.' Be the first to know with the Swindon Advertiser! 📱 💡 Our flash sale brings the latest local happenings directly to you. Save over 50% on an annual subscription now. 🔗 #SpecialOffer — Swindon Advertiser (@swindonadver) July 4, 2025 'That is why Stark has chosen the UK as our first production location outside of Germany – taking advantage of the vast technological, industrial and defence expertise that exists here to create AI-powered, unmanned systems to defend Europe and NATO.' Will Stone, MP for Swindon North, himself a former soldier and at one time a defence sector 'business champion' for the government, said: "I'm proud to be working alongside STARK to bring defence manufacturing back to Swindon, a town with a proud military legacy and key producer of the iconic Supermarine Spitfire. It's fitting that the defence is returning to our town. This is the direction of travel: creating high-skilled, well-paid jobs and putting Swindon back at the heart of Britain's industrial future. This is just the start, with more businesses to follow." The 40,000 square foot factory will be in north central Swindon. Stark was set up only last year, partly as a response to Russia's 2023 invasion of Ukraine. Its 'Virtus' drone has a strike range of up to 100 km, and it carries a five-kilogram payload. Mr Stone said the move was aligned with the government's increased spending on defence and its ambition to make the UK a leader of innovation in NATO, expressed in the Strategic Defence Review. Swindon Borough Council leader Councillor Jim Robbins was also very pleased at the announcement. He said: 'This is fantastic news for Swindon and a strong endorsement of our town's growing reputation in advanced manufacturing and innovation. Stark's investment is a major step forward in our ambition to position Swindon as a national leader in advanced defence manufacturing. 'I'd like to personally thank Swindon North MP, Will Stone, who has played a pivotal role in bringing this investment to our town. I'm excited to see this cutting-edge UAV technology take shape right here in Swindon.'
Sydney Morning Herald
16-06-2025
- Business
- Sydney Morning Herald
Embattled Monash IVF moves to block defecting executive's move to rival
Monash IVF is seeking to hobble the defection of one of its top executives as it reels from a series of scandals, investigations and a plunging share price. The embattled fertility giant has launched action in the Supreme Court of Victoria in a bid to limit the work its departing chief operations officer, Dr Hamish Hamilton, is allowed to undertake in a senior role at its biggest rival, Virtus Health. The action comes as Monash was on Monday forced to respond to another please-explain order from the Australian stock exchange over claims it delayed informing the sharemarket of an embryo mix-up – the second such error and resulting notice issued to them this year. After decade in senior roles at Monash IVF, including the last five as its chief operating officer, Hamilton last week began duties as Virtus' chief operating officer and head of international business. His departure and the related court battle add to the public troubles for Monash IVF – including a $56 million class action involving more than 700 patients, two separate cases of women being implanted with a wrong embryo and the resignation of its chief executive officer – which have prompted an overhaul of the way Australia's reproductive technology sector is regulated. As investigations continue into how its patients were affected by its recent errors, Monash IVF on Monday focussed its attention on the court proceedings where it sought an injunction to prevent Hamilton undertaking aspects of his new role. Appearing for Monash IVF, Richard Dalton, KC, asked the court to impose limits on Hamilton's employment at Virtus until March 3, 2026, stating he had been the 'author' of Monash IVF's Vision 2026 strategic business plan and was well placed to act on commercial secrets. Monash IVF sought orders barring Hamilton from overseeing 'non-core IVF activities' such as day hospitals, ultrasounds and donor banks within Australia, and instead requested he be limited to overseeing Virtus' international donor operations. 'Dr Hamilton, as COO, was instrumental in that strategy and he knows what Monash IVF's plans are,' Dalton said.
The Age
16-06-2025
- Business
- The Age
Embattled Monash IVF moves to hobble defecting executive's move to rival
Monash IVF is seeking to hobble the defection of one of its top executives as it reels from a series of scandals, investigations and a plunging share price. The embattled fertility giant has launched action in the Supreme Court of Victoria in a bid to limit the work its departing chief operations officer, Dr Hamish Hamilton, is allowed to undertake in a senior role at its biggest rival, Virtus Health. The action comes as Monash was on Monday forced to respond to another please-explain order from the Australian stock exchange over claims it delayed informing the sharemarket of an embryo mix-up – the second such error and resulting notice issued to them this year. After decade in senior roles at Monash IVF, including the last five as its chief operating officer, Hamilton last week began duties as Virtus' chief operating officer and head of international business. His departure and the related court battle add to the public troubles for Monash IVF – including a $56 million class action involving more than 700 patients, two separate cases of women being implanted with a wrong embryo and the resignation of its chief executive officer – which have prompted an overhaul of the way Australia's reproductive technology sector is regulated. As investigations continue into how its patients were affected by its recent errors, Monash IVF on Monday focussed its attention on the court proceedings where it sought an injunction to prevent Hamilton undertaking aspects of his new role. Appearing for Monash IVF, Richard Dalton, KC, asked the court to impose limits on Hamilton's employment at Virtus until March 3, 2026, stating he had been the 'author' of Monash IVF's Vision 2026 strategic business plan and was well placed to act on commercial secrets. Monash IVF sought orders barring Hamilton from overseeing 'non-core IVF activities' such as day hospitals, ultrasounds and donor banks within Australia, and instead requested he be limited to overseeing Virtus' international donor operations. 'Dr Hamilton, as COO, was instrumental in that strategy and he knows what Monash IVF's plans are,' Dalton said.
Sydney Morning Herald
16-06-2025
- Business
- Sydney Morning Herald
Embattled Monash IVF moves to hobble defecting executive's move to rival
Monash IVF is seeking to hobble the defection of one of its top executives as it reels from a series of scandals, investigations and a plunging share price. The embattled fertility giant has launched action in the Supreme Court of Victoria in a bid to limit the work its departing chief operations officer, Dr Hamish Hamilton, is allowed to undertake in a senior role at its biggest rival, Virtus Health. The action comes as Monash was on Monday forced to respond to another please-explain order from the Australian stock exchange over claims it delayed informing the sharemarket of an embryo mix-up – the second such error and resulting notice issued to them this year. After decade in senior roles at Monash IVF, including the last five as its chief operating officer, Hamilton last week began duties as Virtus' chief operating officer and head of international business. His departure and the related court battle add to the public troubles for Monash IVF – including a $56 million class action involving more than 700 patients, two separate cases of women being implanted with a wrong embryo and the resignation of its chief executive officer – which have prompted an overhaul of the way Australia's reproductive technology sector is regulated. As investigations continue into how its patients were affected by its recent errors, Monash IVF on Monday focussed its attention on the court proceedings where it sought an injunction to prevent Hamilton undertaking aspects of his new role. Appearing for Monash IVF, Richard Dalton, KC, asked the court to impose limits on Hamilton's employment at Virtus until March 3, 2026, stating he had been the 'author' of Monash IVF's Vision 2026 strategic business plan and was well placed to act on commercial secrets. Monash IVF sought orders barring Hamilton from overseeing 'non-core IVF activities' such as day hospitals, ultrasounds and donor banks within Australia, and instead requested he be limited to overseeing Virtus' international donor operations. 'Dr Hamilton, as COO, was instrumental in that strategy and he knows what Monash IVF's plans are,' Dalton said.
